Glucose Tolerance in Patients with Cystic Fibrosis: Five Year Prospective Study

Overview

Journal BMJ

Specialty General Medicine

Date 1995 Sep 9

PMID 7549632

Citations 46

Authors

S Lanng

A Hansen

B Thorsteinsson

J Nerup

C Koch

Affiliations

Soon will be listed here.

Abstract

Objectives: To study prevalence and incidence of diabetes mellitus in patients with cystic fibrosis.

Design: Five year prospective study with annual oral glucose tolerance tests.

Setting: CF Center Copenhagen, Denmark.

Subjects: 191 patients with cystic fibrosis aged above 2 years.

Main Outcome Measures: Glucose tolerance, plasma glucose concentrations after fasting and after glucose loading, and haemoglobin A1c levels.

Results: Prevalence of diabetes increased from 11% (n = 21) to 24% (n = 46) during study, with annual age dependent incidence of 4-9%. Diabetes was diagnosed at median age of 21 (range 3-40). At diagnosis of diabetes, symptoms of hyperglycaemia were present in 33% of patients, fasting hyperglycaemia (> or = 7.8 mmol/l) was seen in 16%, and increased haemoglobin A1c levels (> 6.4%) were seen in 16%. Impaired glucose tolerance implied higher risk for development of diabetes than normal glucose tolerance (odds ratio 5.6). In 58% of cases with impaired glucose tolerance, however, glucose tolerance was normal at next annual test. Normal glucose tolerance was found in only 37% of patients at all five tests. Within this group of patients, median plasma glucose concentrations after fasting and after glucose loading and haemoglobin A1c levels increased by 6-8% during study.

Conclusions: Prevalence and incidence of diabetes in cystic fibrosis patients was high and increased with age. Since hyperglycaemic symptoms, fasting hyperglycaemia, and increased levels of glycated haemoglobin did not reliably identify diabetes mellitus, we recommend annual oral glucose tolerance tests in all cystic fibrosis patients aged over 10 years.

Citing Articles

Mixed Comparative Evaluation of a Training Program Dedicated to Cystic Fibrosis Reference Centers: Protocol for the Pilot Implementation of Shared Decision-Making in the Treatment of Diabetes in Adult Patients With Cystic Fibrosis.

Moumjid N, Gotte C, Hommey S, Poupon Bourdy S, Haesebaert J, Durieu I JMIR Res Protoc. 2025; 14:e62931.

PMID: 39874570 PMC: 11815300. DOI: 10.2196/62931.

Evaluation of Oral Glucose Tolerance Test Results in Children with Cystic Fibrosis.

Bestas A, Unal E, Aktar Karakaya A, Beyazit N, Savas S, Sen V Sisli Etfal Hastan Tıp Bul. 2024; 58(3):389-394.

PMID: 39411039 PMC: 11472201. DOI: 10.14744/SEMB.2024.65983.

Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.

Scully K, Brenner L, Martin K, Ruazol M, Sawicki G, Uluer A Front Endocrinol (Lausanne). 2024; 15:1293709.

PMID: 38379863 PMC: 10876871. DOI: 10.3389/fendo.2024.1293709.

Muscle oxygen utilization and ventilatory parameters during exercise in people with cystic fibrosis: Role of HbA.

Quertermous B, Seigler N, Looney J, Crandall R, Simon A, Blackburn M Chron Respir Dis. 2023; 20:14799731231174542.

PMID: 37166356 PMC: 10184196. DOI: 10.1177/14799731231174542.

Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study.

Foppiani A, Ciciriello F, Bisogno A, Bricchi S, Colombo C, Alghisi F J Pers Med. 2023; 13(3).

PMID: 36983651 PMC: 10056682. DOI: 10.3390/jpm13030469.

References

Schwartz M, Johansen H, Koch C, BRANDT N . Frequency of the delta F508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet. 1990; 85(4):427-8. DOI: 10.1007/BF02428297. View

Reisman J, Corey M, Canny G, Levison H . Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics. 1990; 86(3):374-7. View

Moran A, Diem P, Klein D, Levitt M, Robertson R . Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991; 118(5):715-23. DOI: 10.1016/s0022-3476(05)80032-0. View

Lanng S, Thorsteinsson B, Erichsen G, Nerup J, Koch C . Glucose tolerance in cystic fibrosis. Arch Dis Child. 1991; 66(5):612-6. PMC: 1792959. DOI: 10.1136/adc.66.5.612. View

Trezise A, Buchwald M . In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator. Nature. 1991; 353(6343):434-7. DOI: 10.1038/353434a0. View

Lanng S, Schwartz M, Thorsteinsson B, Koch C . Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis. Clin Genet. 1991; 40(5):345-8. DOI: 10.1111/j.1399-0004.1991.tb03107.x. View

Elborn J, Shale D, Britton J . Cystic fibrosis: current survival and population estimates to the year 2000. Thorax. 1991; 46(12):881-5. PMC: 463492. DOI: 10.1136/thx.46.12.881. View

Robert J, GRASSET E, de Montalembert M, Chevenne D, DESCHAMPS I, Boitard C . [Research of factors for glucose intolerance in mucoviscidosis]. Arch Fr Pediatr. 1992; 49(1):17-22. View

Lanng S, Thorsteinsson B, Nerup J, Koch C . Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr. 1992; 151(9):684-7. DOI: 10.1007/BF01957574. View

10.

Lanng S, Thorsteinsson B, Pociot F, Marshall M, Madsen H, Schwartz M . Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr. 1993; 82(2):150-4. DOI: 10.1111/j.1651-2227.1993.tb12628.x. View

11.

Lanng S, Thorsteinsson B, Roder M, Orskov C, Holst J, Nerup J . Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh). 1993; 128(3):207-14. DOI: 10.1530/acta.0.1280207. View

12.

Arrigo T, Cucinotta D, Conti Nibali S, Di Cesare E, Di Benedetto A, Magazzu G . Longitudinal evaluation of glucose tolerance and insulin secretion in non-diabetic children and adolescents with cystic fibrosis: results of a two-year follow-up. Acta Paediatr. 1993; 82(3):249-53. DOI: 10.1111/j.1651-2227.1993.tb12653.x. View

13.

LITTLE R, England J, Wiedmeyer H, Madsen R, Pettitt D, Knowler W . Glycated haemoglobin predicts progression to diabetes mellitus in Pima Indians with impaired glucose tolerance. Diabetologia. 1994; 37(3):252-6. DOI: 10.1007/BF00398051. View

14.

Lanng S, Thorsteinsson B, Nerup J, Schiotz P, Koch C . Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr. 1994; 83(1):72-7. DOI: 10.1111/j.1651-2227.1994.tb12956.x. View

15.

Lanng S, Thorsteinsson B, Nerup J, Koch C . Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr. 1994; 83(8):849-53. DOI: 10.1111/j.1651-2227.1994.tb13156.x. View

16.

Gibson L, COOKE R . A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959; 23(3):545-9. View

17.

Handwerger S, Roth J, Gorden P, di Sant Agnese P, Carpenter D, Peter G . Glucose intolerance in cystic fibrosis. N Engl J Med. 1969; 281(9):451-61. DOI: 10.1056/NEJM196908282810901. View

18.

Bank S, Marks I, Vinik A . Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol. 1975; 64(1):13-22. View

19.

Banauch D, Brummer W, Ebeling W, Metz H, Rindfrey H, Lang H . [A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)]. Z Klin Chem Klin Biochem. 1975; 13(3):101-7. View

20.

Nielsen O, FLENSBORG E . [Sweat electrolyte analysis by pilocarpine iontophoresis]. Ugeskr Laeger. 1981; 143(36):2302-6. View